Form 4: Marsh & McLennan Executive South Martin Executes Stock Option Exercises and Sales
SEC Form 4 Filing
South Martin, President & CEO of Marsh, exercised stock options and sold shares of Marsh & McLennan Companies, Inc. on March 6, 2024.
Summary
- On March 6, 2024, South Martin, President & CEO of Marsh, executed transactions involving Marsh & McLennan Companies, Inc. (MMC) common stock.
- Martin exercised stock options to acquire 11,619 shares and 4,294 shares at exercise prices of $83.046 and $73.195 respectively.
- Following the exercise of these options, Martin sold 3,066 shares at a weighted average price of $203.5834 and 11,619 shares at a weighted average price of $203.3849.
- After these transactions, Martin directly owns 8,859.934 shares of MMC common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment, but rather reports factual information.
Industry Context
Executive stock transactions are a normal part of corporate governance and executive compensation. Monitoring these transactions can provide insights into an executive's perspective on the company's value.
Comparison to Industry Standards
- Executive stock option exercises and sales are common across publicly traded companies, particularly in the financial services sector.
- The vesting schedules and exercise prices are typical for executive compensation packages.
- Comparable companies such as Aon and Willis Towers Watson also have executives who regularly exercise stock options and sell shares.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership.
- The transactions reflect executive compensation practices, which are of interest to shareholders.
Key Dates
| Date | Description |
|---|---|
| 02/21/2018 | Date when 11,619 stock options were granted, vesting in four equal annual installments. |
| 02/20/2028 | Expiration date of the 11,619 stock options granted on February 21, 2018. |
| 02/22/2021 | Date when 4,294 stock options were granted, vesting in four equal annual installments. |
| 02/21/2027 | Expiration date of the 4,294 stock options granted on February 22, 2021. |
| 03/06/2024 | Date of stock option exercises and sales of common stock. |
| 03/08/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.